Literature DB >> 21766434

Case-control studies for identifying novel teratogens.

Martha M Werler1, Carol Louik, Allen A Mitchell.   

Abstract

The case-control study design offers an operationally efficient approach to measuring an association between an exposure and an outcome, especially when the outcome is rare, as is true for specific birth defects. For example, instead of following 50,000 pregnant women to have sufficient statistical power to identify a doubling in risk of oral clefts associated with a common exposure (e.g., cigarette smoking), 75 cases and 3 controls per case could be studied with equal statistical power. Examples of case sources include hospital or clinical series, or birth defect registries. For validity, control subjects should represent the population base of the cases, which can be difficult to identify for non-population-based case groups. Case-control studies typically rely on retrospective exposure measurement, which presents a major challenge and sets up the possibility of recall bias. Approaches are discussed to keep sources of bias to a minimum, including recall, non-differential information, and selection biases. Case-control studies can play an important role in this process for both hypothesis-generation and hypothesis-testing of potential teratogens. Examples of case-control studies and their contributions to the field are presented. © 2011 Wiley-Liss, Inc.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21766434      PMCID: PMC3483035          DOI: 10.1002/ajmg.c.30307

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  35 in total

1.  Reproducibility and validity of maternal recall of pregnancy-related events.

Authors:  C A Tomeo; J W Rich-Edwards; K B Michels; C S Berkey; D J Hunter; A L Frazier; W C Willett; S L Buka
Journal:  Epidemiology       Date:  1999-11       Impact factor: 4.822

2.  Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.

Authors:  Michael Schatz; Christina D Chambers; Kenneth Lyons Jones; Carol Louik; Allen A Mitchell
Journal:  Am J Obstet Gynecol       Date:  2011-02-18       Impact factor: 8.661

3.  The National Birth Defects Prevention Study.

Authors:  P W Yoon; S A Rasmussen; M C Lynberg; C A Moore; M Anderka; S L Carmichael; P Costa; C Druschel; C A Hobbs; P A Romitti; P H Langlois; L D Edmonds
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

4.  Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?

Authors:  A Must; S M Phillips; E N Naumova; M Blum; S Harris; B Dawson-Hughes; W M Rand
Journal:  Am J Epidemiol       Date:  2002-04-01       Impact factor: 4.897

5.  Prospective versus retrospective approach in the search for environmental causes of malformations.

Authors:  A Klemetti; L Saxén
Journal:  Am J Public Health Nations Health       Date:  1967-12

6.  Guidelines for case classification for the National Birth Defects Prevention Study.

Authors:  Sonja A Rasmussen; Richard S Olney; Lewis B Holmes; Angela E Lin; Kim M Keppler-Noreuil; Cynthia A Moore
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-03

7.  Maternal obesity and risk for birth defects.

Authors:  Margaret L Watkins; Sonja A Rasmussen; Margaret A Honein; Lorenzo D Botto; Cynthia A Moore
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

8.  Exogenous hormones and other drug exposures of children with congenital heart disease.

Authors:  K J Rothman; D C Fyler; A Goldblatt; M B Kreidberg
Journal:  Am J Epidemiol       Date:  1979-04       Impact factor: 4.897

9.  Integration of DNA sample collection into a multi-site birth defects case-control study.

Authors:  Sonja A Rasmussen; Edward J Lammer; Gary M Shaw; Richard H Finnell; Robert E McGehee; Margaret Gallagher; Paul A Romitti; Jeffrey C Murray
Journal:  Teratology       Date:  2002-10

10.  Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects.

Authors:  A A Mitchell; L Rosenberg; S Shapiro; D Slone
Journal:  JAMA       Date:  1981-06-12       Impact factor: 56.272

View more
  8 in total

1.  Original Findings and Updated Meta-Analysis for the Association Between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes.

Authors:  Thanh T Hoang; Lisa K Marengo; Laura E Mitchell; Mark A Canfield; A J Agopian
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

2.  Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.

Authors:  Elizabeth C Ailes; Suzanne M Gilboa; Simerpal K Gill; Cheryl S Broussard; Krista S Crider; Robert J Berry; Tonia C Carter; Charlotte A Hobbs; Julia D Interrante; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

3.  Congenital Malformations and Consequential Epidemiology.

Authors:  Martha M Werler
Journal:  Curr Epidemiol Rep       Date:  2015-03

4.  Adjusting for bias due to incomplete case ascertainment in case-control studies of birth defects.

Authors:  Penelope P Howards; Candice Y Johnson; Margaret A Honein; W Dana Flanders
Journal:  Am J Epidemiol       Date:  2015-03-19       Impact factor: 4.897

Review 5.  Interpreting the pharmacoepidemiology literature in obstetrical studies: A guide for clinicians.

Authors:  Laura J Rasmussen-Torvik; Katelyn B Zumpf; Hannah K Betcher; Jody D Ciolino
Journal:  Semin Perinatol       Date:  2020-02-28       Impact factor: 3.300

6.  Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.

Authors:  Mayura U Shinde; Ann M Vuong; Jean D Brender; Martha M Werler; Katherine E Kelley; John C Huber; Joseph R Sharkey; Qi Zheng; Lucina Suarez; Peter H Langlois; Mark A Canfield; Paul A Romitti; Sadia Malik
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-05-28

7.  Challenges in Studying Modifiable Risk Factors for Birth Defects.

Authors:  Sarah C Tinker; Suzanne Gilboa; Jennita Reefhuis; Mary M Jenkins; Marcy Schaeffer; Cynthia A Moore
Journal:  Curr Epidemiol Rep       Date:  2015-03

Review 8.  Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events.

Authors:  Alan Leviton
Journal:  Nutrients       Date:  2018-08-23       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.